| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 105.13B | 99.11B | 116.01B | 175.85B | 179.08B | 135.21B |
| Gross Profit | 8.44B | 10.47B | 9.25B | 14.70B | 17.00B | 12.91B |
| EBITDA | 1.45B | 1.52B | 1.67B | 5.23B | 7.37B | 4.53B |
| Net Income | 578.00M | 1.13B | 506.00M | 3.19B | 4.71B | 2.82B |
Balance Sheet | ||||||
| Total Assets | 80.26B | 80.80B | 80.05B | 99.81B | 98.83B | 88.95B |
| Cash, Cash Equivalents and Short-Term Investments | 29.68B | 30.33B | 31.61B | 13.39B | 10.93B | 10.71B |
| Total Debt | 9.30B | 5.30B | 10.15B | 17.57B | 17.95B | 11.28B |
| Total Liabilities | 27.99B | 27.25B | 27.51B | 43.69B | 46.26B | 37.00B |
| Stockholders Equity | 51.42B | 52.65B | 51.70B | 55.33B | 51.86B | 51.37B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.73B | 31.64B | 4.55B | -1.04B | -11.90B |
| Operating Cash Flow | 0.00 | 5.82B | 31.72B | 4.70B | -905.00M | -11.63B |
| Investing Cash Flow | 0.00 | -389.00M | -3.09B | 105.00M | 9.00M | -407.00M |
| Financing Cash Flow | 0.00 | -6.77B | -11.56B | -2.76B | 682.00M | 4.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥202.85B | 5.88 | 17.09% | 2.94% | 20.29% | 94.13% | |
72 Outperform | ¥55.32B | 14.67 | ― | 4.12% | 6.27% | 31.76% | |
67 Neutral | ¥21.59B | 15.35 | ― | 3.83% | 21.81% | -49.75% | |
64 Neutral | ¥40.20B | 8.77 | ― | 5.16% | 1.23% | -22.74% | |
62 Neutral | ¥13.10B | 9.34 | ― | 4.62% | -0.44% | -13.10% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥47.44B | 32.39 | 1.55% | 1.34% | -14.56% | 181.24% |